CPG Island methylation of TMS1/ASC and CASP8 genes in cervical cancer

European Journal of Medical Research

Volumn 14, Issue 2, 2009, Pages 71-75

  Tamandani, Dor Mohammad Kordi ^a,b   Sobti, R C ^a   Shekari, M ^a,c   Huria, A ^d  

^a PANJAB UNIVERSITY   (India)

^b UNIVERSITY OF SISTAN AND BALUCHESTAN   (Iran)

^c HORMOZGAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Cervical cancer; CMSP8; Methylation; TMS1 ASC

Indexed keywords

BISULFITE; CASPASE 8; CHROMOSOME PROTEIN; CYTOSINE; GENOMIC DNA; PROTEIN ASC; PROTEIN TMS1; UNCLASSIFIED DRUG; URACIL;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GEL ELECTROPHORESIS; GENE AMPLIFICATION; GENE TARGETING; GENETIC CORRELATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL RECORD; POLYMERASE CHAIN REACTION; PREVALENCE; SMOKING HABIT; TUMOR DIFFERENTIATION; UTERINE CERVIX CANCER;

CASPASE 8; CPG ISLANDS; CYTOSKELETAL PROTEINS; DNA METHYLATION; FEMALE; HUMANS; INDIA; SMOKING; UTERINE CERVICAL NEOPLASMS;

EID: 61849143698     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: 10.1186/2047-783x-14-2-71     Document Type: Article

References (39)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. 2003 Cancer statistics. CA Cancer J. Clin 53, 5-26.
2. Adcock IM, Ford P, Barnes PJ, Ito K. 2006. Epigenetics and airways disease. Respir Res. 6, 21
3. Chen, W. et al. 2004.Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis. Cancer Cell. 6, 387-398.
4. Wolf BB, Green DR. 1999.Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem. 274, 20049-20052
5. Gonzalez-Gomez P, Bello MJ, Inda MM, Alonso ME, Arjona D, Aminoso C, Lopez-Marin I, de Campos JM, Sarasa JL, Castresana JS, Rey JA: 2004. Deletion and aberrant CpG island methylation of Caspase 8 gene in medulloblastoma. Oncol Rep. 12, 663-666.
6. Philchenkov A, Zavelevich M, Tadeusz J. Kroczak. 2004. Caspases and cancer: mechanisms of inactivation and new treatment modalities. Exp Oncol. 26, 82-97.
7. McConnell BB, Vertino PM. 2000. Activation of a caspase-9-mediated apoptotic pathway by subcellular redistribution of the novel caspase recruitment domain protein TMS1. Cancer Res. 60, 6243-7.
8. McConnell BB, Vertino PM. 2004. TMS1/ASC: the cancer connection. Apoptosis. 9, 5-18.
9. Grenier JM, Wang L, Manji GA, Huang WJ, Al-Garawi A, Kelly R, Carlson A, Merriam S, Lora JM, Briskin M, DiStefano PS, Bertin J. 2002.Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF-kappaB and caspase-1. FEBS Lett. 530, 73-78.
10. Virmani A, Rathi A, Sugio K, Sathyanarayana UG, Toyooka S, Kischel FC, Tonk V, Padar A, Takahashi T, Roth JA, Euhus DM, Minna JD, Gazdar AF. 2003. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer. Int J Cancer. 106, 198-204
11. Stone AR, Bobo W, Brat DJ, Devi NS, Van Meir EG, Vertino PM. 2004. Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma. Am J Pathol. 165, 1151-1161.
12. Dhillon VS, Aslam M, Husain SA. 2004.The contribution of genetic and epigenetic changes in granulosa cell tumors of ovarian origin. Clin Cancer Res. 10, 5537-5545.
13. Yokoyama T, Sagara J, Guan X, Masumoto J, Takeoka M, Komiyama Y, Miyata K, Higuchi K, Taniguchi S. 2003.Methylation of ASC/TMS1, a proapoptotic gene responsible for activating procaspase-1, in human colorectal cancer. Cancer Lett. 202, 101-108.
14. Alaminos M, Davalos V, Cheung NK, Gerald WL, Esteller M. 2004.Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. J Natl Cancer Inst. 96, 1208-1219.
15. Guan X, Sagara J, Yokoyama T, Koganehira Y, Oguchi M, Saida T, Taniguchi S. 2003. ASC/TMS1, a caspase-1 activating adaptor, is downregulated by aberrant methylation in human melanoma. Int J Cancer. 107, 202-208.
16. Roman-Gomez J, Jimenez-Velasco A, Castillejo JA, Agirre X, Barrios M, Navarro G, Molina FJ, Calasanz MJ, Prosper F, Heiniger A, Torres A. 2004. Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood. 104, 2492-2498.
17. Tischoff, H Witzgmann, J Hauss C Wittekind, A Tannapfel. 2006. CpG island methylation of proapoptotic genes in hepatocellular carcinoma and cholangiocarcinoma. Z Gastroenterol. 44 DOI: 10.1055/s-2006-931705.
18. Roe BA, Crabtree JS, Khan AS. 1995. Methods for DNA isolation. Part III. In: Protocols for recombinant DNA isolation, cloning, and sequencing [Internet edition]. Norman, OK: University of Oklahoma;. Available from: http://www.genome.ou.edu/protocol_book/protocol_index.html; also available in paper copy as: DNA isolation and sequencing; New York: Wiley; 1996
19. Liu X, Zhu S, Zhang H, Xu H, Su H, Li S and Zhou X. 2006. The methylation status of the TMS1/ASC gene in cholangiocarcinoma and its clinical significance. Hepatobiliary Pancreat Dis Int. 5, 449-453.
20. Lázcoz P, Muñoz J, Nistal M, Pestaña A, Encío I, Castresana JS. 2006. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma. BMC Cancer. 25; 6: 254.
21. Jones PA..2003. Epigenetics in carcinogenesis and cancer prevention. Ann N Y Acad Sci. 983, 213-9.
22. Esteller M: 2002. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 21, 5427-5440.
23. Laird PW: 2003.The power and the promise of DNA methylation markers. Nat Rev Cancer. 3, 253-266.
24. Teitz T, Wei T, Valentine MB, et al. 2000. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med. 6, 529-35.
25. Banelli B, Casciano I, Croce M, et al. 2002. Expression and methylation of CASP8 in neuroblastoma: identification of a promoter region. Nat Med. 8. 1333-1335.
26. Conway KE, McConnell BB, Bowring CE, et al. 2000. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation- induced gene silencing in human breast cancers. Cancer Res. 60,6236-42.
27. Terasawa K, Sagae S, Toyota M, Tsukada K, Ogi K, Satoh A, Mita H, et al. 2000. Epigenetic Inactivation of TMS1/ASC in Ovarian Cancer. Clin Cancer Res. 10, 2000-6
28. Masumoto J, Taniguchi S, Ayukawa K, et al. 1999. ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic 60 cells. J Biol Chem. 274, 33835-8.
29. Stimson KM, Vertino PM. 2002. Methylation-mediated silencing of TMS1/ ASC is accompanied by histone hypoacetylation and CpG island localized changes in chromatin architecture. J Biol Chem. 277: 4951-8.
30. Martinez R, Setien F, Voelter C, Casado S, Quesada MP, Schackert G, Esteller M. 2007. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. Carcinogenesis. 28, 1264-8.
31. Ohtsuka T, Liu XF, Koga Y, Kitajima Y, Nakafusa Y, Ha CW, et al. 2006. Methylation-induced silencing of ASC and the effect of expressed ASC on p53-mediated chemosensitivity, in colorectal cancer. Oncogene. 25, 1807-1811.
32. Jens M. Teodoridis, Hall J, Marsh S,. Kannall H, Smyth C, et al., 2005. CpG Island Methylation of DNA Damage Response Genes in Advanced Ovarian Cancer. Cancer Res. 65, 8961-7.
33. Feng Q, Balasubramanian A, Stephen E. Hawes, Toure P, Sow P, Dem A, Dembele B, et al. 2005.Detection of Hypermethylated Genes in Women With and Without Cervical Neoplasia. Journal of the National Cancer Institute. 97, 273-82.
34. Liu X, Zhu S, Zhang H, Xu H, Su H, Li S and Zhou X. 2006. The methylation status of the TMS1/ASC gene in cholangiocarcinoma and its clinical significance. Hepatobiliary Pancreat Dis Int. 5, 449-453.
35. Terasawa K, Sagae S, Toyota M, Tsukada K, Ogi K, Satoh A, Mita H, et al. 2000. Epigenetic Inactivation of TMS1/ASC in Ovarian Cancer. Clin Cancer Res. 10, 2000-6.
36. Michalowski MB, de Fraipont F, Plantaz D, Michelland S, Combaret V, Favrot MC. 2007. Methylation of tumor-suppressor genes in neuroblastoma: The RASSF1A gene is almost always methylated in primary tumors. Pediatr Blood Cancer. Jun 14; [Epub ahead of print
37. Martinez R, Setien F, Voelter C, Casado S, Quesada MP, Schackert G, Esteller M. 2007. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. Carcinogenesis. 28, 1264-8.
38. Yang HJ, Liu VWS, Wang Y, Chan KYK, Tsang PCK, Khoo US, Cheung ANY, Ngan HYS: 2004. Detection of Hypermethylated Genes in Tumour and Plasma of Cervical Cancer Patients. Gynecol Oncol. 93, 435-40.
39. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, et al. MethyLight: a highthroughput assay to measure DNA methylation. Nucleic Acids Res 2000; 28